Direct-acting Antiviral Drugs Market Size, Share, Growth, Forecast | Valuates Reports

Direct Actting Antiviral Drugs Market

The global Direct-acting Antiviral Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, NS3/4A Protease Inhibitors accounting for % of the Direct-acting Antiviral Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

Download Sample Report: https://reports.valuates.com/request/sample/QYRE-Auto-11O2087/Global_Direct_acting_Antiviral_Drugs_Market_Insights_Forecast_to_2028

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Direct-acting Antiviral Drugs market size is valued at US$ million in 2021, while the North America and Europe Direct-acting Antiviral Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Direct-acting Antiviral Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Direct-acting Antiviral Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Direct-acting Antiviral Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Direct-acting Antiviral Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Direct-acting Antiviral Drugs market.

Direct-acting Antiviral Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Direct-acting Antiviral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type
• NS3/4A Protease Inhibitors
• Nucleoside and Nucleotide NS5B Polymerase Inhibitors
• NS5A Inhibitors
• Non-Nucleoside NS5B Polymerase Inhibitors

By Application
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Pharmacies
• Others

By Company
• AbbVie Inc.
• GSK
• Boehringer Ingelheim
• Merck
• Novartis
• Beximco Pharmaceuticals
• Roche
• Bristol-Myers Squibb Company
• Gilead Sciences
• Janssen (Johnson & Johnson)
• Vertex Pharmaceuticals
• Natco Pharma

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-11O2087/global-direct-acting-antiviral-drugs

Similar Reports:

1. HIV Therapeutics Market: https://reports.valuates.com/market-reports/QYRE-Auto-22W5974/global-hiv-therapeutics

2. Antiviral Therapy Market: https://reports.valuates.com/market-reports/QYRE-Auto-2G10409/global-antiviral-therapy

3. Influenza Antiviral Drugs Market: https://reports.valuates.com/market-reports/QYRE-Auto-8J2211/global-influenza-antiviral-drugs

4. Influenza Diagnostics Market: https://reports.valuates.com/reports/QYRE-Auto-13Z613/global-influenza-diagnostics

5. Antiviral Drugs Industry: https://reports.valuates.com/market-reports/QYRE-Othe-2E265/global-antiviral-drugs

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.